Partner Therapeutics

About:

PTx is a biopharmaceutical company committed to the development and commercialization of therapies that improve the treatment of cancer.

Website: https://www.partnertx.com/

Twitter/X: PartnerTx

Top Investors: MidCap Financial, Perceptive Advisors, Adams Street Partners

Description:

Partner Therapeutics is a developer of drugs for oncology treatment. The company focuses on the development and commercialization of approved and late-stage therapies that improve treatment outcomes and reduce the total cost of care for cancer. Its development spans the entire range of cancer therapy from primary treatments to supportive care.

Total Funding Amount:

$60M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

media(AT)partnertx.com

Founders:

Debasish Roychowdhury, Robert J. Mulroy

Number of Employees:

101-250

Last Funding Date:

2018-02-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai